These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30968736)

  • 21. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Characterization and Antimicrobial Activities of 7H-Benzo[h]chromeno[2,3-d]pyrimidine and 14H-Benzo[h]chromeno[3,2-e][1,2,4]triazolo[1,5-c] pyrimidine Derivatives.
    Okasha RM; Albalawi FF; Afifi TH; Fouda AM; Al-Dies AM; El-Agrody AM
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27809292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Docking Studies into CDK-2 and Anticancer Activity of New Derivatives Based Pyrimidine Scaffold and Their Derived Glycosides.
    Rahman AAHA; Nassar IF; Shaban AKF; El-Kady DS; Awad HM; El Sayed WA
    Mini Rev Med Chem; 2019; 19(13):1093-1110. PubMed ID: 30864522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and anticancer activity of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives bearing chromone moiety.
    Sun C; Chen C; Xu S; Wang J; Zhu Y; Kong D; Tao H; Jin M; Zheng P; Zhu W
    Bioorg Med Chem; 2016 Aug; 24(16):3862-9. PubMed ID: 27353887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, In Silico Prediction and In Vitro Evaluation of Antitumor Activities of Novel Pyrido[2,3-
    El-Kalyoubi S; Agili F
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33182318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Design, synthesis and biological evaluation of novel 3-(2-oxo-2-substituted acetamido)benzamides as PARP-1 inhibitors].
    Yin YW; Ji M; Cao R; Chen XG; Xu BL
    Yao Xue Xue Bao; 2015 Jun; 50(6):738-45. PubMed ID: 26521446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, anticancer evaluation, molecular docking and cell cycle analysis of 3-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidine derivatives as potent histone lysine demethylases (KDM) inhibitors and apoptosis inducers.
    Metwally NH; Mohamed MS; Ragb EA
    Bioorg Chem; 2019 Jul; 88():102929. PubMed ID: 31015179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating molecular dynamics-guided lead optimization of EGFR inhibitors.
    Lavecchia MJ; Puig de la Bellacasa R; Borrell JI; Cavasotto CN
    Bioorg Med Chem; 2016 Feb; 24(4):768-78. PubMed ID: 26810832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying new piperazine-based PARP1 inhibitors using text mining and integrated molecular modeling approaches.
    Sahin K; Durdagi S
    J Biomol Struct Dyn; 2021 Feb; 39(2):681-690. PubMed ID: 32048546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors.
    Cherukupalli S; Chandrasekaran B; Kryštof V; Aleti RR; Sayyad N; Merugu SR; Kushwaha ND; Karpoormath R
    Bioorg Chem; 2018 Sep; 79():46-59. PubMed ID: 29753773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1
    Min R; Wu W; Wang M; Tang L; Chen D; Zhao H; Zhang C; Jiang Y
    Molecules; 2019 May; 24(10):. PubMed ID: 31108884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrapolation of phenolic compounds as multi-target agents against cancer and inflammation.
    Kumar N; Gupta S; Chand Yadav T; Pruthi V; Kumar Varadwaj P; Goel N
    J Biomol Struct Dyn; 2019 Jun; 37(9):2355-2369. PubMed ID: 30047324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative structure-activity relationship and molecular docking studies on human proteasome inhibitors for anticancer activity targeting NF-κB signaling pathway.
    Yadav D; Mishra BN; Khan F
    J Biomol Struct Dyn; 2020 Aug; 38(12):3621-3632. PubMed ID: 31514715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.
    Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L
    J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells:
    Chaudhary M; Kumar N; Baldi A; Chandra R; Babu MA; Madan J
    J Biomol Struct Dyn; 2020 Mar; 38(5):1335-1353. PubMed ID: 30957694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
    Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
    Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, computational quantum chemical study, in silico ADMET and molecular docking analysis, in vitro biological evaluation of a novel sulfur heterocyclic thiophene derivative containing 1,2,3-triazole and pyridine moieties as a potential human topoisomerase IIα inhibiting anticancer agent.
    Murugavel S; Ravikumar C; Jaabil G; Alagusundaram P
    Comput Biol Chem; 2019 Apr; 79():73-82. PubMed ID: 30731361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR, molecular docking, and molecular dynamics simulation of a novel thieno[3,4-d]pyrimidine inhibitor targeting human immunodeficiency virus type 1 reverse transcriptase.
    Chu H; He QX; Wang JW; Deng YT; Wang J; Hu Y; Wang YQ; Lin ZH
    J Biomol Struct Dyn; 2020 Sep; 38(15):4567-4578. PubMed ID: 31760877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.